Latest Infrastructure News

Pharmx Technologies has extended its pivotal National Diabetes Services Scheme agreement and expanded its supplier base, reinforcing its leadership in pharmacy digital infrastructure across Australia and New Zealand.

Antilles Gold has taken a major step forward in developing its Nueva Sabana copper-gold mine by signing a non-binding Letter of Intent with Chinese firm Xinhai for a $26 million EPC contract and $16 million in project financing. The agreement also includes a strategic $4.1 million share placement, signaling deeper collaboration and governance involvement.

Coda Minerals has submitted the Draft Scoping Report for its Elizabeth Creek Copper-Cobalt Project, marking a pivotal step in securing mining lease approvals in South Australia. This milestone reduces regulatory uncertainty and sets a clear path toward project development.

Ora Banda Mining delivered a strong FY25 with 92.4koz gold produced, up 32% year-on-year, and sets an ambitious FY26 target of 140-155koz driven by new underground mines and strategic partnerships.

Renascor Resources has secured an option agreement for land near its Siviour graphite deposit, finalising a critical step in supporting its upstream mining and processing operations. This move advances the company’s Battery Anode Material project readiness with accommodation planned for construction and operational staff.

Chariot Corporation Ltd is set to acquire a 66.7% interest in a substantial Nigerian lithium portfolio, marking a strategic entry into Africa’s burgeoning lithium sector with a US$10 million funding commitment.

Mindax Limited has raised $1.6 million through a discounted share placement to fund development and exploration activities at its Mt Forrest Iron Project and gold assets.

Imricor Medical Systems has secured key European regulatory approvals for its second-generation NorthStar system and initiated its commercial launch, while US FDA submissions progress amid some delays.

Race Oncology has secured key ethics approvals to launch its Phase 1 RC220 trial at two major Hong Kong hospitals, marking a strategic expansion beyond Australia to accelerate patient recruitment and explore cardioprotective benefits.

Kinterra Infrastructure has increased its takeover offer for New World Resources shares to A$0.063, with a potential rise to A$0.064 if it secures over 30% ownership. This move intensifies the takeover battle against rival CAML, promising quicker payments and stronger funding assurances.

Spectur Ltd reports a stronger cash position driven by operational improvements and strategic cloud investments, while FY25 revenue slightly misses guidance due to delayed orders.

Orthocell has achieved a significant milestone by recording its first US sales revenue for Remplir™, its flagship nerve repair product, shortly after FDA clearance and initial surgical use.